[{"address1": "2000 Sierra Point Parkway", "address2": "Suite 400", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "415 798 8589", "website": "https://www.tempesttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat cancer; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, an enzyme that regulates cGAS/STING pathway signaling and immune recognition. The company has agreement with Roche to advance the evaluation of amezalpat (TPST-1120) in combination with atezolizumab (Tecentriq\u00ae) and bevacizumab. Tempest Therapeutics, Inc. was incorporated in 2011 and is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.", "fullTimeEmployees": 17, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen R. Brady J.D., LLM", "age": 54, "title": "CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 923235, "exercisedValue": 0, "unexercisedValue": 262204}, {"maxAge": 1, "name": "Mr. Nicholas  Maestas", "age": 43, "title": "CFO, Head of Corporate Strategy & Secretary", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 465429, "exercisedValue": 0, "unexercisedValue": 67328}, {"maxAge": 1, "name": "Dr. Samuel  Whiting M.D., Ph.D.", "age": 57, "title": "Executive VP, Chief Medical Officer and Head of R&D", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 667651, "exercisedValue": 0, "unexercisedValue": 93438}, {"maxAge": 1, "name": "Mr. Justin  Trojanowski CPA", "age": 36, "title": "Corporate Controller, Treasurer & Principal Accounting Officer", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lindsay  Young", "title": "Head of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.84, "open": 0.79, "dayLow": 0.77, "dayHigh": 0.827, "regularMarketPreviousClose": 0.84, "regularMarketOpen": 0.79, "regularMarketDayLow": 0.77, "regularMarketDayHigh": 0.827, "payoutRatio": 0.0, "beta": -2.57, "forwardPE": -0.5594927, "volume": 506848, "regularMarketVolume": 506848, "averageVolume": 867793, "averageVolume10days": 381210, "averageDailyVolume10Day": 381210, "bid": 0.56, "ask": 1.0, "bidSize": 1, "askSize": 2, "marketCap": 33696064, "fiftyTwoWeekLow": 0.699, "fiftyTwoWeekHigh": 6.0, "fiftyDayAverage": 0.86484, "twoHundredDayAverage": 1.24285, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 32281340, "profitMargins": 0.0, "floatShares": 40048147, "sharesOutstanding": 43642100, "sharesShort": 1752444, "sharesShortPriorMonth": 2109508, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0402, "heldPercentInsiders": 0.0016500001, "heldPercentInstitutions": 0.15539, "shortRatio": 3.01, "shortPercentOfFloat": 0.0437, "impliedSharesOutstanding": 43642100, "bookValue": 0.431, "priceToBook": 1.7914152, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -35518000, "trailingEps": -1.5, "forwardEps": -1.38, "lastSplitFactor": "1:15", "lastSplitDate": 1624838400, "enterpriseToEbitda": -0.917, "52WeekChange": -0.85808825, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 0.7721, "targetHighPrice": 16.0, "targetLowPrice": 5.0, "targetMeanPrice": 9.5, "targetMedianPrice": 8.5, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 22116000, "totalCashPerShare": 0.507, "ebitda": -35197000, "totalDebt": 17738000, "quickRatio": 1.583, "currentRatio": 1.686, "debtToEquity": 154.822, "returnOnAssets": -0.77007, "returnOnEquity": -6.9188704, "freeCashflow": -17905500, "operatingCashflow": -29053000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TPST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -1.5, "epsForward": -1.38, "epsCurrentYear": -1.275, "priceEpsCurrentYear": -0.6055686, "fiftyDayAverageChange": -0.09274, "fiftyDayAverageChangePercent": -0.10723371, "twoHundredDayAverageChange": -0.47074997, "twoHundredDayAverageChangePercent": -0.37876654, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Tempest Therapeutics Inc.", "nameChangeDate": "2025-03-28", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "regularMarketChangePercent": -8.083334, "corporateActions": [], "postMarketTime": 1743205462, "regularMarketTime": 1743192000, "exchange": "NCM", "messageBoardId": "finmb_552715229", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Tempest Therapeutics, Inc.", "regularMarketPrice": 0.7721, "longName": "Tempest Therapeutics, Inc.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1352730600000, "postMarketChangePercent": 0.168377, "postMarketPrice": 0.7734, "postMarketChange": 0.00130004, "regularMarketChange": -0.0679, "regularMarketDayRange": "0.77 - 0.827", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 867793, "fiftyTwoWeekLowChange": 0.07309997, "fiftyTwoWeekLowChangePercent": 0.10457793, "fiftyTwoWeekRange": "0.699 - 6.0", "fiftyTwoWeekHighChange": -5.2279, "fiftyTwoWeekHighChangePercent": -0.8713167, "fiftyTwoWeekChangePercent": -85.80882, "dividendDate": 1544400000, "earningsTimestamp": 1743106257, "earningsTimestampStart": 1746615540, "earningsTimestampEnd": 1747051200, "isEarningsDateEstimate": true, "displayName": "Tempest Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]